An involvement of GSK3β in mediating tumorigenic pathways is also indicated by its induced expression in various cancers including colon cancer [17], pancreatic cancer [18, 19], prostate cancer [20–22], and glioblastoma [23]. This evidence concerns the gene GSK3B and malignant colon neoplasm.